302 related articles for article (PubMed ID: 15932502)
1. Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of pro-inflammatory cytokines in lamina propria mononuclear cells.
Matsumoto S; Hara T; Hori T; Mitsuyama K; Nagaoka M; Tomiyasu N; Suzuki A; Sata M
Clin Exp Immunol; 2005 Jun; 140(3):417-26. PubMed ID: 15932502
[TBL] [Abstract][Full Text] [Related]
2. A component of polysaccharide peptidoglycan complex on Lactobacillus induced an improvement of murine model of inflammatory bowel disease and colitis-associated cancer.
Matsumoto S; Hara T; Nagaoka M; Mike A; Mitsuyama K; Sako T; Yamamoto M; Kado S; Takada T
Immunology; 2009 Sep; 128(1 Suppl):e170-80. PubMed ID: 19740306
[TBL] [Abstract][Full Text] [Related]
3. Selective effects of Lactobacillus casei Shirota on T cell activation, natural killer cell activity and cytokine production.
Dong H; Rowland I; Tuohy KM; Thomas LV; Yaqoob P
Clin Exp Immunol; 2010 Aug; 161(2):378-88. PubMed ID: 20456417
[TBL] [Abstract][Full Text] [Related]
4. IL-10 secretion and sensitivity in normal human intestine and inflammatory bowel disease.
Gasche C; Bakos S; Dejaco C; Tillinger W; Zakeri S; Reinisch W
J Clin Immunol; 2000 Sep; 20(5):362-70. PubMed ID: 11051278
[TBL] [Abstract][Full Text] [Related]
5. Fucoidan derived from Cladosiphon okamuranus Tokida ameliorates murine chronic colitis through the down-regulation of interleukin-6 production on colonic epithelial cells.
Matsumoto S; Nagaoka M; Hara T; Kimura-Takagi I; Mistuyama K; Ueyama S
Clin Exp Immunol; 2004 Jun; 136(3):432-9. PubMed ID: 15147344
[TBL] [Abstract][Full Text] [Related]
6. Dysregulated circulating dendritic cell function in ulcerative colitis is partially restored by probiotic strain Lactobacillus casei Shirota.
Mann ER; You J; Horneffer-van der Sluis V; Bernardo D; Omar Al-Hassi H; Landy J; Peake ST; Thomas LV; Tee CT; Lee GH; Hart AL; Yaqoob P; Knight SC
Mediators Inflamm; 2013; 2013():573576. PubMed ID: 23970814
[TBL] [Abstract][Full Text] [Related]
7. Live and heat-killed probiotic Lactobacillus casei Lbs2 protects from experimental colitis through Toll-like receptor 2-dependent induction of T-regulatory response.
Thakur BK; Saha P; Banik G; Saha DR; Grover S; Batish VK; Das S
Int Immunopharmacol; 2016 Jul; 36():39-50. PubMed ID: 27107798
[TBL] [Abstract][Full Text] [Related]
8. Probiotic effects of Lactobacillus casei on DSS-induced ulcerative colitis in mice.
Herías MV; Koninkx JF; Vos JG; Huis in't Veld JH; van Dijk JE
Int J Food Microbiol; 2005 Aug; 103(2):143-55. PubMed ID: 16083817
[TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma (IFN-gamma) and prostaglandin E2 (PGE2) regulate differently IL-12 production in human intestinal lamina propria mononuclear cells (LPMC).
Monteleone G; Parrello T; Monteleone I; Tammaro S; Luzza F; Pallone F
Clin Exp Immunol; 1999 Sep; 117(3):469-75. PubMed ID: 10469049
[TBL] [Abstract][Full Text] [Related]
10.
Wong WY; Chan BD; Sham TT; Lee MM; Chan CO; Chau CT; Mok DK; Kwan YW; Tai WC
Front Nutr; 2022; 9():816836. PubMed ID: 35529468
[TBL] [Abstract][Full Text] [Related]
11. Local and systemic liberation of proinflammatory cytokines in ulcerative colitis.
Gotteland M; Lopez M; Muñoz C; Saez R; Altshiller H; Llorens P; Brunser O
Dig Dis Sci; 1999 Apr; 44(4):830-5. PubMed ID: 10219845
[TBL] [Abstract][Full Text] [Related]
12. Human gut dendritic cells drive aberrant gut-specific t-cell responses in ulcerative colitis, characterized by increased IL-4 production and loss of IL-22 and IFNγ.
Mann ER; Bernardo D; Ng SC; Rigby RJ; Al-Hassi HO; Landy J; Peake ST; Spranger H; English NR; Thomas LV; Stagg AJ; Knight SC; Hart AL
Inflamm Bowel Dis; 2014 Dec; 20(12):2299-307. PubMed ID: 25397892
[TBL] [Abstract][Full Text] [Related]
13. Decreased production of interleukin-10 and transforming growth factor-β in Toll-like receptor-activated intestinal B cells in SAMP1/Yit mice.
Mishima Y; Ishihara S; Aziz MM; Oka A; Kusunoki R; Otani A; Tada Y; Li YY; Moriyama I; Oshima N; Yuki T; Amano Y; Matsumoto S; Kinoshita Y
Immunology; 2010 Dec; 131(4):473-87. PubMed ID: 20561083
[TBL] [Abstract][Full Text] [Related]
14. Lysate of probiotic Lactobacillus casei DN-114 001 ameliorates colitis by strengthening the gut barrier function and changing the gut microenvironment.
Zakostelska Z; Kverka M; Klimesova K; Rossmann P; Mrazek J; Kopecny J; Hornova M; Srutkova D; Hudcovic T; Ridl J; Tlaskalova-Hogenova H
PLoS One; 2011; 6(11):e27961. PubMed ID: 22132181
[TBL] [Abstract][Full Text] [Related]
15. Immune Response of Healthy Adults to the Ingested Probiotic Lactobacillus casei Shirota.
Harbige LS; Pinto E; Allgrove J; Thomas LV
Scand J Immunol; 2016 Dec; 84(6):353-364. PubMed ID: 27718254
[TBL] [Abstract][Full Text] [Related]
16. Oral administration of Lactobacillus plantarum K68 ameliorates DSS-induced ulcerative colitis in BALB/c mice via the anti-inflammatory and immunomodulatory activities.
Liu YW; Su YW; Ong WK; Cheng TH; Tsai YC
Int Immunopharmacol; 2011 Dec; 11(12):2159-66. PubMed ID: 21996541
[TBL] [Abstract][Full Text] [Related]
17. Well-controlled proinflammatory cytokine responses of Peyer's patch cells to probiotic Lactobacillus casei.
Chiba Y; Shida K; Nagata S; Wada M; Bian L; Wang C; Shimizu T; Yamashiro Y; Kiyoshima-Shibata J; Nanno M; Nomoto K
Immunology; 2010 Jul; 130(3):352-62. PubMed ID: 20636824
[TBL] [Abstract][Full Text] [Related]
18. Enhanced interferon-gamma production and B7-2 expression in isolated intestinal mononuclear cells from patients with Crohn's disease.
Noguchi M; Hiwatashi N; Liu Z; Toyota T
J Gastroenterol; 1995 Nov; 30 Suppl 8():52-5. PubMed ID: 8563891
[TBL] [Abstract][Full Text] [Related]
19. Probiotic Lactobacillus casei strain Shirota prevents indomethacin-induced small intestinal injury: involvement of lactic acid.
Watanabe T; Nishio H; Tanigawa T; Yamagami H; Okazaki H; Watanabe K; Tominaga K; Fujiwara Y; Oshitani N; Asahara T; Nomoto K; Higuchi K; Takeuchi K; Arakawa T
Am J Physiol Gastrointest Liver Physiol; 2009 Sep; 297(3):G506-13. PubMed ID: 19589943
[TBL] [Abstract][Full Text] [Related]
20. Glycogen synthase kinase 3-β: a master regulator of toll-like receptor-mediated chronic intestinal inflammation.
Hofmann C; Dunger N; Schölmerich J; Falk W; Obermeier F
Inflamm Bowel Dis; 2010 Nov; 16(11):1850-8. PubMed ID: 20848477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
